Ray Dalio's NUVL Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 15,020 shares of Nuvalent, Inc. (NUVL) worth $1.54 M, representing 0.01% of the portfolio. First purchased in 2025-Q3, this short-term holding has been held for 3 quarters.
Based on 13F filings, Ray Dalio has maintained this position in NUVL for several quarters, showing initial confidence in the investment. Largest reduction occurred in Q1 2026, reducing 3,558 shares.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's Nuvalent (NUVL) Holding Value Over Time
Track share changes against reported price movement
Quarterly Nuvalent (NUVL) Trades by Ray Dalio
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -3,558 | Reduce 19.15% | 15,020 | $102.45 |
| Q4 2025 | -3,479 | Reduce 15.77% | 18,578 | $100.59 |
| Q3 2025 | +22,057 | New Buy | 22,057 | $86.48 |
Ray Dalio's Nuvalent Investment FAQs
Ray Dalio first purchased Nuvalent, Inc. (NUVL) in Q3 2025, acquiring 22,057 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held Nuvalent, Inc. (NUVL) for 3 quarters since Q3 2025.
Ray Dalio's largest addition to Nuvalent, Inc. (NUVL) was in Q3 2025, adding 22,057 shares worth $1.91 M.
According to the latest 13F filing for Q1 2026, Ray Dalio's firm, Bridgewater Associates, Lp, owns 15,020 shares of Nuvalent, Inc. (NUVL), valued at approximately $1.54 M.
As of the Q1 2026 filing, Nuvalent, Inc. (NUVL) represents approximately 0.01% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings.
Ray Dalio's peak holding in Nuvalent, Inc. (NUVL) was 22,057 shares, as reported at the end of Q3 2025.